Evaluating the impact of access to a palliative outpatient clinic on patient security and healthcare utilization
Official title: Experience of Security Having Access to Specialized Palliative Care Clinic
Run by Region Skane · NCT06393569 · Data updated 2026-11-12
This study is trying to see if having access to a special palliative outpatient clinic makes cancer patients feel safer and helps them use healthcare services better compared to those who don’t have access.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 120 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Region Skane Academic / other |
| Locations | 1 site (Lund) |
| Status | Recruiting |
| Started | March 14, 2024 |
| Main results expected | March 14, 2028 |
| Study ends | March 14, 2029 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT06393569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are cancer patients who are being referred to a specialized palliative outpatient clinic.
✕Probably not a fit
Patients with cognitive impairments or those unable to complete questionnaires in the required languages may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the experiences of patients with cancer who have access to a specialized palliative outpatient clinic compared to those who do not. It focuses on aspects such as feelings of security, accessibility to care, and the utilization of healthcare services. The study aims to gather insights from both patients and their relatives to understand the effectiveness of early palliative care integration. By adopting a holistic, person-centered approach, the study seeks to improve the quality of life for patients facing life-threatening illnesses.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for cancer patients by demonstrating the value of early palliative care integration.
How similar studies have gone: Other studies have shown positive outcomes with early integration of palliative care, suggesting that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients admitted to included ASiH-unit Exclusion Criteria: * Patients with cognitive impairment * Patients who cannot fill in a questionnaire in Swedish, Arabic or Serbo-Croatian.
Where it's running
-
ASiH och palliativ vård Skåne
Lund, Sweden Recruiting
Study contacts
- Principal investigator: Maria Schelin, ass.prof — Region Skane
- Study coordinator: Sofia Persson, PhD student
- Email: sofia.persson@skane.se
- Phone: +46708652769
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.